NMCG President & Principal Consultant, Michael Nilo, will join Greenlight Guru for this AMA session of The Future of MedTech Virtual Summit to help decode major regulatory changes and what they mean for growing medtech companies. Attendees will leave with clear action steps and an understanding that flexible, audit-ready tools help teams stay compliant without heavy lifting.

Key topics:

• QMSR is coming: what’s new and how it aligns to ISO 13485

• AI/ML and SaMD: upcoming regulations and how to stay ahead

• Where most startups stumble on compliance (and how to avoid it)

• Tools that automate readiness without requiring massive headcount

• Ultralight as a low-lift way to stay aligned with evolving global regs

• Government shutdown: long term impacts

• AI in medtech

Join us for a high-impact evening of networking, tacos, and medtech strategy—timed to coincide with the RAPS Convergence 2025 conference in Pittsburgh.

This casual but purposeful mixer is designed for regulatory affairs professionals, medical device companies, and hiring managers looking to grow their team’s capabilities or tap into expert support. Whether you're attending RAPS as a solo RA lead or representing a larger org, this event is a great way to connect with peers and potential partners.

We're also excited to feature indieMedTech, the newest social and professional network dedicated entirely to MedTech professionals to come together, collaborate, and build lasting partnerships.

What to Expect:

• Mingle with regulatory professionals and medtech innovators

• Free food and drinks at Bakersfield (just steps from the convention center!)

• A 30-minute strategy session (during the RAPS conference or by teleconference at a later date) included with ticket—tailored to your medical device or combination product needs

• An exclusive indieMedTech offer—a first month free coupon code

• 50% discount for students registering with a valid .edu email (discount code: MEDTECHSTUDENT)

We’ll be there to talk clinical trial support, supplemental regulatory bandwidth, KOL engagement, and how our team can help yours navigate challenges and scale smarter.

Limited spots available—reserve your ticket today.This event is independently hosted and not affiliated with RAPS.

Tickets are $50, plus applicable taxes and fees. Purchase now: https://bit.ly/41hgadN

For startups aiming to raise capital, clinical data can be the tipping point. But generating the right kind of data at the right sites, with the right partners, can make all the difference. This panel brings together CEOs, investors, and clinical experts to share how strategic site partnerships can accelerate trials, strengthen credibility, and build the investor confidence needed to scale.

In this session, you’ll hear from:
• Aneta Sottil — Partner, Andera Partners
• Stephen Wildhirt, M.D., Ph.D. — CEO & Co-Founder, AdjuCor GmbH
• Marina Izzo — CEO, EBAMed
• Megan Lamberti — Vice President of Clinical and Regulatory Affairs, Nilo Medical Consulting Group
• Marc Zemel — CEO, Retia Medical

Want to join us at LSI Europe ‘25 Emerging MedTech Summit? Price increases on August 1st. Register today for your opportunity to connect with the industry's top decision-makers at LSI Europe ‘25 on September 7-11 in London.